Taking the potential harms of psychedelic-assisted therapy seriously: How do we prevent or mitigate the risks to vulnerable patients?
Int J Drug Policy – July 26, 2024
Source: PubMed
Summary
Despite the therapeutic promise of psychedelics, safeguarding vulnerable patients is critical. This work highlights the need for robust safeguards in emerging psychedelic therapies. It details how careful patient selection, specialized therapist training, and structured therapeutic environments are essential. These strategies effectively prevent or mitigate potential risks, maximizing therapeutic benefits and ensuring patient well-being.
Abstract
Taking the potential harms of psychedelic-assisted therapy seriously: How do we prevent or mitigate the risks to vulnerable patients?